XML 110 R11.htm IDEA: XBRL DOCUMENT v2.3.0.15
Fair Value Measurement
9 Months Ended
Sep. 30, 2011
Fair Value Disclosures [Abstract] 
FAIR VALUE MEASUREMENT
FAIR VALUE MEASUREMENT
For a further discussion of the Firm’s valuation methodologies for assets, liabilities and lending-related commitments measured at fair value and the fair value hierarchy, see Note 3 on pages 170–187 of JPMorgan Chase’s 2010 Annual Report.
During the first nine months of 2011, no changes were made to the Firm’s valuation models that had, or were expected to have, a material impact on the Firm’s Consolidated Balance Sheets or results of operations.
The following table presents the assets and liabilities measured at fair value as of September 30, 2011, and December 31, 2010, by major product category and fair value hierarchy.
Assets and liabilities measured at fair value on a recurring basis
 
Fair value hierarchy
 
 
September 30, 2011 (in millions)
Level 1(h)
Level 2(h)
Level 3(h)
Netting
adjustments
Total
fair value
Federal funds sold and securities purchased under resale agreements
$

$
22,192

$

$

$
22,192

Securities borrowed

14,648



14,648

Trading assets:
 
 
 
 
 
Debt instruments:
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
U.S. government agencies(a)
23,919

8,084

95


32,098

Residential – nonagency

2,981

807


3,788

Commercial – nonagency

897

1,835


2,732

Total mortgage-backed securities
23,919

11,962

2,737


38,618

U.S. Treasury and government agencies(a)
14,892

10,316



25,208

Obligations of U.S. states and municipalities

13,632

1,565


15,197

Certificates of deposit, bankers’ acceptances and commercial paper

2,292



2,292

Non-U.S. government debt securities
26,137

44,388

98


70,623

Corporate debt securities

38,039

5,260


43,299

Loans(b)

22,152

11,584


33,736

Asset-backed securities

3,373

8,441


11,814

Total debt instruments
64,948

146,154

29,685


240,787

Equity securities
83,696

2,586

1,206


87,488

Physical commodities(c)
18,135

3,193



21,328

Other

2,187

888


3,075

Total debt and equity instruments(d)
166,779

154,120

31,779


352,678

Derivative receivables:
 
 
 
 
 
Interest rate
1,318

1,479,047

6,791

(1,436,508
)
50,648

Credit

176,346

20,173

(189,486
)
7,033

Foreign exchange
2,348

217,414

4,542

(198,417
)
25,887

Equity
97

60,235

4,155

(55,983
)
8,504

Commodity
9,359

53,457

4,027

(50,062
)
16,781

Total derivative receivables(e)
13,122

1,986,499

39,688

(1,930,456
)
108,853

Total trading assets
179,901

2,140,619

71,467

(1,930,456
)
461,531

Available-for-sale securities:
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
U.S. government agencies(a)
93,991

16,011



110,002

Residential – nonagency

59,405

3


59,408

Commercial – nonagency

6,997

278


7,275

Total mortgage-backed securities
93,991

82,413

281


176,685

U.S. Treasury and government agencies(a)
3,159

4,531



7,690

Obligations of U.S. states and municipalities
36

15,028

258


15,322

Certificates of deposit

4,973



4,973

Non-U.S. government debt securities
21,335

14,487



35,822

Corporate debt securities

60,422



60,422

Asset-backed securities:
 
 
 
 
 
Credit card receivables

4,989



4,989

Collateralized loan obligations

116

21,317


21,433

Other

9,168

213


9,381

Equity securities
2,581

38



2,619

Total available-for-sale securities
121,102

196,165

22,069


339,336

Loans

383

1,614


1,997

Mortgage servicing rights


7,833


7,833

Other assets:
 
 
 
 
 
Private equity investments(f)
130

579

6,589


7,298

All other
4,191

155

4,487


8,833

Total other assets
4,321

734

11,076


16,131

Total assets measured at fair value on a recurring basis(g)
$
305,324

$
2,374,741

$
114,059

$
(1,930,456
)
$
863,668

Deposits
$

$
4,166

$
650

$

$
4,816

Federal funds purchased and securities loaned or sold under repurchase agreements

7,011



7,011

Other borrowed funds

7,532

1,849


9,381

Trading liabilities:
 
 
 
 


Debt and equity instruments(d)
54,948

21,334

310


76,592

Derivative payables:
 
 
 
 


Interest rate
1,320

1,437,986

3,324

(1,417,263
)
25,367

Credit

179,964

11,336

(185,085
)
6,215

Foreign exchange
2,553

204,699

6,130

(191,165
)
22,217

Equity
75

49,074

7,543

(47,506
)
9,186

Commodity
8,267

55,283

4,794

(52,080
)
16,264

Total derivative payables(e)
12,215

1,927,006

33,127

(1,893,099
)
79,249

Total trading liabilities
67,163

1,948,340

33,437

(1,893,099
)
155,841

Accounts payable and other liabilities


68


68

Beneficial interests issued by consolidated VIEs

541

364


905

Long-term debt

22,724

13,141


35,865

Total liabilities measured at fair value on a recurring basis
$
67,163

$
1,990,314

$
49,509

$
(1,893,099
)
$
213,887

 
Fair value hierarchy
 
 
December 31, 2010 (in millions)
Level 1
Level 2
Level 3
Netting
adjustments
Total
fair value
Federal funds sold and securities purchased under resale agreements
$

$
20,299

$

$

$
20,299

Securities borrowed

13,961



13,961

Trading assets:
 
 
 
 
 
Debt instruments:
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
U.S. government agencies(a)
36,813

10,738

174


47,725

Residential – nonagency

2,807

687


3,494

Commercial – nonagency

1,093

2,069


3,162

Total mortgage-backed securities
36,813

14,638

2,930


54,381

U.S. Treasury and government agencies(a)
12,863

9,026



21,889

Obligations of U.S. states and municipalities

11,715

2,257


13,972

Certificates of deposit, bankers’ acceptances and commercial paper

3,248



3,248

Non-U.S. government debt securities
31,127

38,482

202


69,811

Corporate debt securities

42,280

4,946


47,226

Loans(b)

21,736

13,144


34,880

Asset-backed securities

2,743

8,460


11,203

Total debt instruments
80,803

143,868

31,939


256,610

Equity securities
124,400

3,153

1,685


129,238

Physical commodities(c)
18,327

2,708



21,035

Other

1,598

930


2,528

Total debt and equity instruments(d)
223,530

151,327

34,554


409,411

Derivative receivables:
 
 
 
 
 
Interest rate
2,278

1,120,282

5,422

(1,095,427
)
32,555

Credit

111,827

17,902

(122,004
)
7,725

Foreign exchange
1,121

163,114

4,236

(142,613
)
25,858

Equity
30

38,718

4,885

(39,429
)
4,204

Commodity
1,324

56,076

2,197

(49,458
)
10,139

Total derivative receivables(e)
4,753

1,490,017

34,642

(1,448,931
)
80,481

Total trading assets
228,283

1,641,344

69,196

(1,448,931
)
489,892

Available-for-sale securities:
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
U.S. government agencies(a)
104,736

15,490



120,226

Residential – nonagency
1

48,969

5


48,975

Commercial – nonagency

5,403

251


5,654

Total mortgage-backed securities
104,737

69,862

256


174,855

U.S. Treasury and government agencies(a)
522

10,826



11,348

Obligations of U.S. states and municipalities
31

11,272

256


11,559

Certificates of deposit
6

3,641



3,647

Non-U.S. government debt securities
13,107

7,670



20,777

Corporate debt securities

61,793



61,793

Asset-backed securities:
 
 
 
 
 
Credit card receivables

7,608



7,608

Collateralized loan obligations

128

13,470


13,598

Other

8,777

305


9,082

Equity securities
1,998

53



2,051

Total available-for-sale securities
120,401

181,630

14,287


316,318

Loans

510

1,466


1,976

Mortgage servicing rights


13,649


13,649

Other assets:
 
 
 
 
 
Private equity investments(f)
49

826

7,862


8,737

All other
5,093

192

4,179


9,464

Total other assets
5,142

1,018

12,041


18,201

Total assets measured at fair value on a recurring basis(g)
$
353,826

$
1,858,762

$
110,639

$
(1,448,931
)
$
874,296

Deposits
$

$
3,596

$
773

$

$
4,369

Federal funds purchased and securities loaned or sold under repurchase agreements

4,060



4,060

Other borrowed funds

8,547

1,384


9,931

Trading liabilities:
 
 
 
 
 
Debt and equity instruments(d)
58,468

18,425

54


76,947

Derivative payables:
 
 
 
 
 
Interest rate
2,625

1,085,233

2,586

(1,070,057
)
20,387

Credit

112,545

12,516

(119,923
)
5,138

Foreign exchange
972

158,908

4,850

(139,715
)
25,015

Equity
22

39,046

7,331

(35,949
)
10,450

Commodity
862

54,611

3,002

(50,246
)
8,229

Total derivative payables(e)
4,481

1,450,343

30,285

(1,415,890
)
69,219

Total trading liabilities
62,949

1,468,768

30,339

(1,415,890
)
146,166

Accounts payable and other liabilities


236


236

Beneficial interests issued by consolidated VIEs

622

873


1,495

Long-term debt

25,795

13,044


38,839

Total liabilities measured at fair value on a recurring basis
$
62,949

$
1,511,388

$
46,649

$
(1,415,890
)
$
205,096

(a)
At September 30, 2011, and December 31, 2010, included total U.S. government-sponsored enterprise obligations of $123.0 billion and $137.3 billion respectively, which were predominantly mortgage-related.
(b)
At September 30, 2011, and December 31, 2010, included within trading loans were $19.9 billion and $22.7 billion, respectively, of residential first-lien mortgages, and $1.8 billion and $2.6 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. government agencies of $11.3 billion and $13.1 billion, respectively, and reverse mortgages of $4.0 billion and $4.0 billion, respectively.
(c)
Physical commodities inventories are generally accounted for at the lower of cost or fair value.
(d)
Balances reflect the reduction of securities owned (long positions) by the amount of securities sold but not yet purchased (short positions) when the long and short positions have identical Committee on Uniform Security Identification Procedures numbers (“CUSIPs”).
(e)
As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. For purposes of the tables above, the Firm does not reduce derivative receivables and derivative payables balances for this netting adjustment, either within or across the levels of the fair value hierarchy, as such netting is not relevant to a presentation based on the transparency of inputs to the valuation of an asset or liability. Therefore, the balances reported in the fair value hierarchy table are gross of any counterparty netting adjustments. However, if the Firm were to net such balances within level 3, the reduction in the level 3 derivative receivable and payable balances would be $15.2 billion and $12.7 billion at September 30, 2011, and December 31, 2010, respectively; this is exclusive of the netting benefit associated with cash collateral, which would further reduce the level 3 balances.
(f)
Private equity instruments represent investments within the Corporate/Private Equity line of business. The cost basis of the private equity investment portfolio totaled $9.5 billion and $10.0 billion at September 30, 2011, and December 31, 2010, respectively.
(g)
At September 30, 2011, and December 31, 2010, balances included investments valued at net asset values of $11.0 billion and $12.1 billion, respectively, of which $5.0 billion and $5.9 billion, respectively, were classified in level 1, $1.5 billion and $2.0 billion, respectively, in level 2, and $4.5 billion and $4.2 billion, respectively, in level 3.
(h)
For the nine months ended September 30, 2011 and 2010, the transfers between levels 1, 2 and 3, were not significant. All transfers are assumed to occur at the beginning of the reporting period.
Changes in level 3 recurring fair value measurements
The following tables include a rollforward of the balance sheet amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the three and nine months ended September 30, 2011 and 2010. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable parameters to the overall fair value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments.

 
Fair value measurements using significant unobservable inputs
 
Three months ended
September 30, 2011
Fair value at June 30, 2011
Total realized/unrealized
gains/(losses)
 
 
 
 
Transfers into and/or
out of
level 3(g)
Fair value at
Sept. 30, 2011
Change in unrealized
gains/(losses) related to financial instruments held
at Sept. 30, 2011
(in millions)
Purchases(f)
Sales
Issuances
Settlements
Assets:
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
U.S. government agencies
$
165

$
3

 
$

$

$

$
(15
)
$
(58
)
$
95

$
(6
)
 
Residential – nonagency
863

(13
)
 
104

(98
)

(51
)
2

807

(41
)
 
Commercial – nonagency
1,843

12

 
121

(82
)

(59
)

1,835

2

 
Total mortgage-backed securities
2,871

2

 
225

(180
)

(125
)
(56
)
2,737

(45
)
 
Obligations of U.S. states and municipalities
1,855

11

 
68

(369
)



1,565

10

 
Non-U.S. government debt securities
82

5

 
201

(166
)

(24
)

98

5

 
Corporate debt securities
5,606

(60
)
 
1,388

(1,570
)

(175
)
71

5,260

(35
)
 
Loans
11,742

14

 
1,547

(988
)

(880
)
149

11,584

(81
)
 
Asset-backed securities
8,319

(453
)
 
1,698

(1,065
)

(61
)
3

8,441

(458
)
 
Total debt instruments
30,475

(481
)
 
5,127

(4,338
)

(1,265
)
167

29,685

(604
)
 
Equity securities
1,408

75

 
40

(272
)

(22
)
(23
)
1,206

51

 
Other
908

(2
)
 
9

(2
)

(25
)

888

(12
)
 
Total debt and equity instruments
32,791

(408
)
(b) 
5,176

(4,612
)

(1,312
)
144

31,779

(565
)
(b) 
Net derivative receivables:
 
 
 
 
 
 
 
 
 
 
 
Interest rate
3,117

1,943

 
97

(52
)

(1,432
)
(206
)
3,467

931

 
Credit
4,733

3,909

 
19

(7
)

183


8,837

3,712

 
Foreign exchange
(536
)
(1,236
)
 
51

(15
)

179

(31
)
(1,588
)
(1,250
)
 
Equity
(3,203
)
(85
)
 
117

(309
)

91

1

(3,388
)
(177
)
 
Commodity
(1,274
)
380

 
64

(5
)

(22
)
90

(767
)
287

 
Total net derivative receivables
2,837

4,911

(b) 
348

(388
)

(1,001
)
(146
)
6,561

3,503

(b) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
15,402

(453
)
 
9,349

(1,392
)

(1,376
)

21,530

(457
)
 
Other
501

(2
)
 
57



(17
)

539

(2
)
 
Total available-for-sale securities
15,903

(455
)
(c) 
9,406

(1,392
)

(1,393
)

22,069

(459
)
(c) 
Loans
1,472

167

(b) 
120

(9
)

(151
)
15

1,614

163

(b) 
Mortgage servicing rights
12,243

(4,575
)
(d) 
624



(459
)

7,833

(4,575
)
(d) 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
Private equity investments
8,022

(469
)
(b) 
49

(691
)

(156
)
(166
)
6,589

(372
)
(b) 
All other
4,449

(50
)
(e) 
154

(19
)

(47
)

4,487

(56
)
(e) 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
Three months ended
September 30, 2011
Fair value at June 30, 2011
Total realized/unrealized
(gains)/losses
 
 
 
 
Transfers into and/or
out of
level 3(g)
Fair value at
Sept. 30, 2011
Change in unrealized
(gains)/losses related to financial instruments held
at Sept. 30, 2011
(in millions)
Purchases(f)
Sales
Issuances
Settlements
Liabilities(a):
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
863

$
(1
)
(b) 
$

$

$
29

$
(241
)
$

$
650

$
(11
)
(b) 
Other borrowed funds
2,078

(241
)
(b) 


157

(145
)

1,849

(7
)
(b) 
Trading liabilities – debt and equity instruments
197

7

(b) 
(111
)
296


(79
)

310


(b) 
Accounts payable and other liabilities
73

1

(e) 



(6
)

68

1

(e) 
Beneficial interests issued by consolidated VIEs
430

10

(b) 


2

(78
)

364

(4
)
(b) 
Long-term debt
13,534

(131
)
(b) 


394

(865
)
209

13,141

98

(b) 
 
Fair value measurements using significant unobservable inputs
 
Three months ended
September 30, 2010
Fair value at June 30, 2010
Total realized/ unrealized gains/(losses)
Purchases, issuances, settlements, net
Transfers
into and/or
out of
   level 3(g)
Fair value at Sept. 30, 2010
Change in unrealized gains/(losses) related to financial instruments held Sept. 30, 2010
(in millions)
Assets:
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
U.S. government agencies
$
176

$
3

 
$

$

$
179

$
(9
)
 
Residential – nonagency
804

89

 
(233
)

660

17

 
Commercial – nonagency
1,739

89

 
47


1,875

74

 
Total mortgage-backed securities
2,719

181

 
(186
)

2,714

82

 
Obligations of U.S. states and municipalities
2,008

21

 
21


2,050

19

 
Non-U.S. government debt securities
114

(6
)
 
88

(3
)
193

(5
)
 
Corporate debt securities
4,551

16

 
73

(229
)
4,411

42

 
Loans
14,889

537

 
754

(135
)
16,045

424

 
Asset-backed securities
8,637

409

 
(396
)
1

8,651

330

 
Total debt instruments
32,918

1,158

 
354

(366
)
34,064

892

 
Equity securities
1,822

25

 
14

(74
)
1,787

59

 
Other
920

163

 
(19
)

1,064

170

 
Total debt and equity instruments
35,660

1,346

(b) 
349

(440
)
36,915

1,121

(b) 
Net of derivative receivables:
 
 
 
 
 
 
 
 
Interest rate
3,047

1,444

 
(1,168
)
(26
)
3,297

595

 
Credit
9,786

(1,635
)
 
(132
)
(40
)
7,979

(1,443
)
 
Foreign exchange
51

(596
)
 
471

(12
)
(86
)
(445
)
 
Equity
(2,159
)
(268
)
 
(90
)
75

(2,442
)
(284
)
 
Commodity
(417
)
(74
)
 
(266
)
37

(720
)
(78
)
 
Total net derivative receivables
10,308

(1,129
)
(b) 
(1,185
)
34

8,028

(1,655
)
(b) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
Asset-backed securities
12,334

102

 
1,536


13,972

101

 
Other
410

20

 
76


506

20

 
Total available-for-sale securities
12,744

122

(c) 
1,612


14,478

121

(c) 
Loans
1,065

104

(b) 
56


1,225

97

(b) 
Mortgage servicing rights
11,853

(1,497
)
(d) 
(51
)

10,305

(1,497
)
(d) 
Other assets:
 
 
 
 
 
 
 
 
Private equity investments
7,246

827

(b) 
236

(107
)
8,202

685

(b) 
All other
4,308

(71
)
(b) 
210

(2
)
4,445

7

(b) 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
 
Three months ended
September 30, 2010
Fair value at June 30, 2010
Total realized/ unrealized (gains)/losses
Purchases, issuances, settlements, net
Transfers
into and/or
out of
   level 3(g)
Fair value at Sept. 30, 2010
Change in unrealized (gains)/losses related to financial instruments held Sept. 30, 2010
(in millions)
Liabilities(a):
 
 
 
 
 
 
 
 
Deposits
$
884

$
62

(b) 
$
(84
)
$
20

$
882

$
141

(b) 
Other borrowed funds
291

72

(b) 
942


1,305

68

(b) 
Trading liabilities – debt and equity instruments
4


(b) 
20


24

1

(b) 
Accounts payable and other liabilities
449

(52
)
(e) 
(57
)

340

47

(e) 
Beneficial interests issued by consolidated VIEs
1,392

27

(b) 
(171
)
80

1,328

27

(b) 
Long-term debt
15,762

784

(b) 
(2,303
)
(173
)
14,070

1,056

(b) 



 
Fair value measurements using significant unobservable inputs
 
 
Nine months ended
September 30, 2011
Fair value at January 1, 2011
Total realized/unrealized
gains/(losses)
 
 
 
 
Transfers into and/or
out of
level 3(g)
Fair value at
Sept. 30, 2011
Change in unrealized
gains/(losses) related to financial instruments held at Sept. 30, 2011
(in millions)
Purchases(f)
Sales
Issuances
Settlements
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government agencies
$
174

$
32

 
$
28

$
(39
)
$

$
(42
)
$
(58
)
 
$
95

 
$
(17
)
 
Residential – nonagency
687

114

 
609

(369
)

(175
)
(59
)
 
807

 
12

 
Commercial – nonagency
2,069

59

 
686

(826
)

(153
)

 
1,835

 
34

 
Total mortgage-backed securities
2,930

205

 
1,323

(1,234
)

(370
)
(117
)
 
2,737

 
29

 
Obligations of U.S. states and municipalities
2,257

11

 
624

(1,338
)

(1
)
12

 
1,565

 
(3
)
 
Non-U.S. government debt securities
202

9

 
444

(420
)

(63
)
(74
)
 
98

 
11

 
Corporate debt securities
4,946

(5
)
 
4,817

(4,465
)

(292
)
259

 
5,260

 
(46
)
 
Loans
13,144

335

 
4,161

(3,765
)

(2,033
)
(258
)
 
11,584

 
155

 
Asset-backed securities
8,460

175

 
3,671

(3,526
)

(361
)
22

 
8,441

 
(306
)
 
Total debt instruments
31,939

730

 
15,040

(14,748
)

(3,120
)
(156
)
 
29,685

 
(160
)
 
Equity securities
1,685

315

 
138

(471
)

(398
)
(63
)
 
1,206

 
294

 
Other
930

29

 
28

(14
)

(85
)

 
888

 
32

 
Total debt and equity instruments
34,554

1,074

(b) 
15,206

(15,233
)

(3,603
)
(219
)
 
31,779

 
166

(b) 
Net derivative receivables:
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate
2,836

3,869

 
442

(171
)

(3,335
)
(174
)
 
3,467

 
945

 
Credit
5,386

3,357

 
21

(10
)

102

(19
)
 
8,837

 
3,570

 
Foreign exchange
(614
)
(1,718
)
 
167

(18
)

641

(46
)
 
(1,588
)
 
(300
)
 
Equity
(2,446
)
(63
)
 
352

(881
)

(448
)
98

 
(3,388
)
 
343

 
Commodity
(805
)
669

 
199

(102
)

(563
)
(165
)
 
(767
)
 
162

 
Total net derivative receivables
4,357

6,114

(b) 
1,181

(1,182
)

(3,603
)
(306
)
 
6,561

 
4,720

(b) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Asset-backed securities
13,775

128

 
11,309

(1,418
)

(2,264
)

 
21,530

 
(459
)
 
Other
512

(1
)
 
57

(3
)

(26
)

 
539

 

 
Total available-for-sale securities
14,287

127

(c) 
11,366

(1,421
)

(2,290
)

 
22,069

 
(459
)
(c) 
Loans
1,466

427

(b) 
245

(9
)

(514
)
(1
)
 
1,614

 
397

(b) 
Mortgage servicing rights
13,649

(6,286
)
(d) 
1,973



(1,503
)

 
7,833

 
(6,286
)
(d) 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Private equity investments
7,862

1,213

(b) 
846

(2,736
)

(430
)
(166
)
 
6,589

 
(461
)
(b) 
All other
4,179

(19
)
(e) 
863

(22
)

(485
)
(29
)
 
4,487

 
(23
)
(e) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
 
Nine months ended
September 30, 2011
Fair value at January 1, 2011
Total realized/unrealized
(gains)/losses
 
 
 
 
Transfers into and/or
out of
level 3(g)
Fair value at
Sept. 30, 2011
Change in unrealized
(gains)/losses related to financial instruments held at Sept. 30, 2011
(in millions)
Purchases(f)
Sales
Issuances
Settlements
Liabilities(a):
 
 
 
 
 
 
 
 
 
 
 
 
 
Deposits
$
773

$
(9
)
(b) 
$

$

$
245

$
(358
)
$
(1
)
 
$
650

 
$
(16
)
(b) 
Other borrowed funds
1,384

(267
)
(b) 


1,060

(330
)
2

 
1,849

 
(152
)
(b) 
Trading liabilities – debt and equity instruments
54

2

(b) 
(244
)
573


(79
)
4

 
310

 
(12
)
(b) 
Accounts payable and other liabilities
236

(62
)
(e) 



(106
)

 
68

 
4

(e) 
Beneficial interests issued by consolidated VIEs
873

35

(b) 


116

(660
)

 
364

 
(36
)
(b) 
Long-term debt
13,044

326

(b) 


1,650

(2,327
)
448

 
13,141

 
209

(b) 
 
Fair value measurements using significant unobservable inputs
 
Nine months ended
September 30, 2010
Fair value at January 1, 2010
Total realized/ unrealized gains/(losses)
Purchases, issuances, settlements, net
Transfers
into and/or
out of
   level 3(g)
Fair value at Sept. 30, 2010
Change in unrealized
gains/(losses) related to financial instruments held at Sept. 30, 2010
(in millions)
Assets:
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
Debt instruments:
 
 
 
 
 
 
 
 
Mortgage-backed securities:
 
 
 
 
 
 
 
 
U.S. government agencies
$
260

$
27

 
$
(105
)
$
(3
)
$
179

$
(19
)
 
Residential – nonagency
1,115

166

 
(573
)
(48
)
660

62

 
Commercial – nonagency
1,770

205

 
(97
)
(3
)
1,875

104

 
Total mortgage-backed securities
3,145

398

 
(775
)
(54
)
2,714

147

 
Obligations of U.S. states and municipalities
1,971

(6
)
 
(57
)
142

2,050

(24
)
 
Non-U.S. government debt securities
89

(28
)
 
135

(3
)
193

(10
)
 
Corporate debt securities
5,241

(315
)
 
(394
)
(121
)
4,411

(36
)
 
Loans
13,218

247

 
2,797

(217
)
16,045

278

 
Asset-backed securities
8,620

252

 
(238
)
17

8,651

130

 
Total debt instruments
32,284

548

 
1,468

(236
)
34,064

485

 
Equity securities
1,956

106

 
(217
)
(58
)
1,787

263

 
Other
1,441

219

 
(674
)
78

1,064

219

 
Total debt and equity instruments
35,681

873

(b) 
577

(216
)
36,915

967

(b) 
Net of derivative receivables:
 
 
 
 
 
 
 
 
Interest rate
2,040

2,885

 
(1,743
)
115

3,297

915

 
Credit
10,350

(236
)
 
(2,093
)
(42
)
7,979

291

 
Foreign exchange
1,082

(1,489
)
 
627

(306
)
(86
)
191

 
Equity
(2,306
)
(354
)
 
(86
)
304

(2,442
)
(224
)
 
Commodity
(329
)
(726
)
 
206

129

(720
)
15

 
Total net derivative receivables
10,837

80

(b) 
(3,089
)
200

8,028

1,188

(b) 
Available-for-sale securities:
 
 
 
 
 
 
 
 
Asset-backed securities
12,732

(3
)
 
1,243


13,972

(21
)
 
Other
461

(47
)
 
(13
)
105

506

20

 
Total available-for-sale securities
13,193

(50
)
(c) 
1,230

105

14,478

(1
)
(c) 
Loans
990

93

(b) 
134

8

1,225

41

(b) 
Mortgage servicing rights
15,531

(5,177
)
(d) 
(49
)

10,305

(5,177
)
(d) 
Other assets:
 
 
 
 
 
 
 
 
Private equity investments
6,563

963

(b) 
1,167

(491
)
8,202

697

(b) 
All other
9,521

(129
)
(b) 
(4,850
)
(97
)
4,445

(30
)
(b) 
 
 
 
 
 
 
 
 
 
 
Fair value measurements using significant unobservable inputs
 
Nine months ended
September 30, 2010
Fair value at January 1, 2010
Total realized/ unrealized (gains)/losses
Purchases, issuances, settlements, net
Transfers
into and/or
out of
   level 3(g)
Fair value at Sept. 30, 2010
Change in unrealized (gains)/losses related to financial instruments held at Sept. 30, 2010
(in millions)
Liabilities(a):
 
 
 
 
 
 
 
 
Deposits
$
476

$
67

(b) 
$
10

$
329

$
882

$
11

(b) 
Other borrowed funds
542

(28
)
(b) 
1,034

(243
)
1,305

(7
)
(b) 
Trading liabilities – debt and equity instruments
10

4

(b) 
(13
)
23

24

(1
)
(b) 
Accounts payable and other liabilities
355

(92
)
(e) 
77


340

34

(e) 
Beneficial interests issued by consolidated VIEs
625

(6
)
(b) 
629

80

1,328

(58
)
(b) 
Long-term debt
18,287

(251
)
(b) 
(4,190
)
224

14,070

386

(b) 
(a)
Level 3 liabilities as a percentage of total Firm liabilities accounted for at fair value (including liabilities measured at fair value on a nonrecurring basis) were 23% and 23% at September 30, 2011, and December 31, 2010, respectively.
(b)
Predominantly reported in principal transactions revenue, except for changes in fair value for Retail Financial Services ("RFS") mortgage loans originated with the intent to sell, which are reported in mortgage fees and related income.
(c)
Realized gains/(losses) on available-for-sale (“AFS”) securities, as well as other-than-temporary impairment losses that are recorded in earnings, are reported in securities gains. Unrealized gains/(losses) are reported in other comprehensive income (“OCI”). Realized gains/(losses) and foreign exchange remeasurement adjustments recorded in income on AFS securities were $(426) million and zero for the three months ended September 30, 2011 and 2010, and were $8 million and $(65) million for the nine months ended September 30, 2011 and 2010, respectively. Unrealized gains/(losses) reported on AFS securities in OCI were $(29) million and $122 million for the three months ended September 30, 2011 and 2010, and were $119 million and $15 million for the nine months ended September 30, 2011 and 2010, respectively.
(d)
Changes in fair value for RFS mortgage servicing rights are reported in mortgage fees and related income.
(e)
Largely reported in other income.
(f)
Loan originations are included in purchases.
(g)
All transfers into and/or out of level 3 are assumed to occur at the beginning of the reporting period.
Assets and liabilities measured at fair value on a nonrecurring basis
Certain assets, liabilities and unfunded lending-related commitments are measured at fair value on a nonrecurring basis; that is, they are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). The following tables present the assets and liabilities carried on the Consolidated Balance Sheets by caption and level within the valuation hierarchy as of September 30, 2011, and December 31, 2010, for which a nonrecurring change in fair value has been recorded during the reporting period.
 
Fair value hierarchy
 
 
September 30, 2011 (in millions)
 Level 1(e)
 Level 2(e)
 Level 3(e)
 
Total fair value
Loans retained(a)
$

$
3,191

$
213

 
$
3,404

Loans held-for-sale(b)

604

482

 
1,086

Total loans

3,795

695

 
4,490

Other real estate owned

60

246

 
306

Other assets

15

16

 
31

Total other assets

75

262

 
337

Total assets at fair value on a nonrecurring basis
$

$
3,870

$
957

 
$
4,827

Accounts payable and other liabilities(c)
$

$
43

$
23

 
$
66

Total liabilities at fair value on a nonrecurring basis
$

$
43

$
23

 
$
66

 
 
 
 
 
 
 
Fair value hierarchy
 
 
December 31, 2010 (in millions)
 Level 1
 Level 2
 Level 3
 
Total fair value
Loans retained(a)
$

$
5,484

$
513

(f) 
$
5,997

Loans held-for-sale(b)(d)

312

3,200

 
3,512

Total loans

5,796

3,713

 
9,509

Other real estate owned

78

311

 
389

Other assets


2

 
2

Total other assets

78

313

 
391

Total assets at fair value on a nonrecurring basis
$

$
5,874

$
4,026

 
$
9,900

Accounts payable and other liabilities(c)
$

$
53

$
18

 
$
71

Total liabilities at fair value on a nonrecurring basis
$

$
53

$
18

 
$
71

(a)
Reflects mortgage, home equity and other loans where the carrying value is based on the fair value of the underlying collateral.
(b)
Loans held-for-sale are carried on the Consolidated Balance Sheets at the lower of cost or fair value.
(c)
Represents, at September 30, 2011, and December 31, 2010, fair value adjustments associated with $437 million and $517 million, respectively, of unfunded held-for-sale lending-related commitments within the leveraged lending portfolio.
(d)
Predominantly includes credit card loans at December 31, 2010.
(e)
For the nine months ended September 30, 2011 and 2010, the transfers between levels 1, 2 and 3 were not significant. All transfers are assumed to occur at the beginning of the reporting period.
(f)
The prior period has been revised to conform with the current presentation.
The method used to estimate the fair value of impaired collateral-dependent loans, and other loans where the carrying value is based on the fair value of the underlying collateral (e.g., residential mortgage loans charged off in accordance with regulatory guidance), depends on the type of collateral (e.g., securities, real estate, nonfinancial assets) underlying the loan. Fair value of the collateral is typically estimated based on quoted market prices, broker quotes or independent appraisals. For further information, see Note 14 on pages 158–159 of this Form 10-Q.
Nonrecurring fair value changes
The following table presents the total change in value of assets and liabilities for which a fair value adjustment has been included in the Consolidated Statements of Income for the three- and nine-month periods ended September 30, 2011 and 2010, related to financial instruments held at those dates.
 
Three months ended September 30,
 
Nine months ended September 30,
 
(in millions)
2011
2010
 
2011
2010
 
Loans retained
$
(541
)
$
(951
)
(a) 
$
(1,710
)
$
(1,559
)
(a) 
Loans held-for-sale
(38
)
20

 
(11
)
78

 
Total loans
(579
)
(931
)
 
(1,721
)
(1,481
)
 
Other assets
(31
)
(8
)
 
(71
)
17

 
Accounts payable and other liabilities
(13
)

 
(14
)
5

 
Total nonrecurring fair value gains/(losses)
$
(623
)
$
(939
)
 
$
(1,806
)
$
(1,459
)
 
(a) Prior periods have been revised to conform with the current presentation.
Level 3 analysis
Level 3 assets at September 30, 2011, predominantly included derivative receivables, mortgage servicing rights (“MSRs”), collateralized loan obligations (“CLOs”) held within the AFS and trading portfolios, loans within the trading portfolio and private equity investments.
Derivative receivables included $39.7 billion of interest rate, credit, foreign exchange, equity and commodity contracts . Credit derivative receivables of $20.2 billion included $14.9 billion of structured credit derivatives with corporate debt underlying and $3.5 billion of credit default swaps largely on commercial mortgages where the risks are partially mitigated by similar and offsetting derivative payables. Interest rate derivative receivables of $6.8 billion include long-dated structured interest rate derivatives which are dependent on correlation. Foreign exchange derivative receivables of $4.5 billion included long-dated foreign exchange derivatives which are dependent on the correlation between foreign exchange and interest rates. Equity derivative receivables of $4.2 billion principally included long-dated contracts where the volatility levels are unobservable. Commodity derivative receivables of 4.0 billion largely included long-dated oil contracts.
Mortgage servicing rights represent the fair value of future cash flows for performing specified mortgage servicing activities for others (predominantly with respect to residential mortgage loans). For a further description of the MSR asset, the interest rate risk management and valuation methodology used for MSRs, including valuation assumptions and sensitivities, see Note 17 on pages 260–263 of JPMorgan Chase’s 2010 Annual Report and Note 16 on pages 168–172 of this Form 10-Q.
CLOs totaling $27.9 billion are securities backed by corporate loans. At September 30, 2011, $21.3 billion of CLOs were held in the AFS securities portfolio and $6.6 billion were included in Asset Backed Securities held in the trading portfolio. Substantially all of the securities are rated “AAA,” “AA” and “A” and had an average credit enhancement of 30%. Credit enhancement in CLOs is primarily in the form of subordination, which is a form of structural credit enhancement where realized losses associated with assets held by the issuing vehicle are allocated to the various tranches of securities issued by the vehicle considering their relative seniority. For a further discussion of CLOs held in the AFS securities portfolio, see Note 11 on pages 130–134 of this Form 10-Q.
Trading loans totaling $11.6 billion included $5.5 billion of residential mortgage whole loans and commercial mortgage loans for which there is limited price transparency; and $4.0 billion of reverse mortgages for which the principal risk sensitivities are mortality risk and home prices. The fair value of the commercial and residential mortgage loans is estimated by projecting expected cash flows, considering relevant borrower-specific and market factors, and discounting those cash flows at a rate reflecting current market liquidity. Loans are partially hedged by level 2 instruments, including credit default swaps and interest rate derivatives, for which valuation inputs are observable and liquid.
Consolidated Balance Sheets changes
Level 3 assets (including assets measured at fair value on a nonrecurring basis) were 5% of total Firm assets at September 30, 2011. The following describes significant changes to level 3 assets since December 31, 2010.
For the three months ended September 30, 2011
Level 3 assets were $115.0 billion at September 30, 2011, reflecting an increase of $5.2 billion from the second quarter largely related to a:
$6.2 billion increase in asset-backed AFS securities, predominantly driven by purchases of CLOs;
$5.5 billion increase in derivative receivables due to widening of credit spreads;
$4.4 billion decrease in MSRs. For further discussion of the change, refer to Note 16 on pages 168–172 of this Form 10-Q; and
$1.4 billion decrease in private equity investments, predominantly driven by net write-downs on private investments and sales.
For the nine months ended September 30, 2011
Level 3 assets increased by $351 million in the first nine months of 2011, due to the following:
$7.8 billion increase in asset-backed AFS securities, predominantly driven by purchases of CLOs;
$5.0 billion increase in derivative receivables due to widening of credit spreads, changes in interest rates and price movements in energy;
$5.8 billion decrease in MSRs. For further discussion of the change, refer to Note 16 on pages 168–172 of this Form 10-Q;
$2.8 billion decrease in trading assets – debt and equity instruments, largely driven by sales of trading loans;
$2.7 billion decrease in nonrecurring loans held-for-sale, predominantly driven by sales in the loan portfolios; and
$1.3 billion decrease in private equity investments, predominantly driven by sales of investments, partially offset by net increases in investment valuations and follow-on investments.
Gains and Losses
Included in the tables for the three months ended September 30, 2011
$4.9 billion of net gains on derivatives, predominantly driven by widening of credit spreads; and
$4.6 billion of losses on MSRs. For further discussion of the change, refer to Note 16 on pages 168–172 of this Form 10-Q.
Included in the tables for the three months ended September 30, 2010
$1.1 billion of net losses on derivatives, largely due to the tightening of credit spreads;
$1.3 billion of net gains on trading assets-debt and equity securities largely due to asset-backed securities and trading loans;
$784 million in gains related to long-term structured note liabilities, largely due to foreign exchange revaluation;
$827 million of gains in private equity largely driven by gains in investments in the portfolio; and
$1.5 billion of losses on MSRs.
Included in the tables for the nine months ended September 30, 2011
$6.3 billion of losses on MSRs. For further discussion of the change, refer to Note 16 on pages 168–172 of this Form 10-Q;
$6.1 billion of net gains on derivatives, related to widening of credit spreads and changes in interest rates, partially offset by losses due to fluctuation in foreign exchange rates; and
$1.2 billion gain in private equity, primarily driven by gains on sales and net increases in investment valuations.
Included in the tables for the nine months ended September 30, 2010
$5.2 billion of losses on MSRs; and
$963 million gain in private equity largely driven by gains in investments in the portfolio
Credit adjustments
When determining the fair value of an instrument, it may be necessary to record a valuation adjustment to arrive at an exit price under U.S. GAAP. Valuation adjustments include, but are not limited to, amounts to reflect counterparty credit quality and the Firm’s own creditworthiness. The market’s view of the Firm’s credit quality is reflected in credit spreads observed in the credit default swap market. For a detailed discussion of the valuation adjustments the Firm considers, see Note 3 on pages 170–187 of JPMorgan Chase’s 2010 Annual Report.
The following table provides the credit adjustments, excluding the effect of any hedging activity, reflected within the Consolidated Balance Sheets as of the dates indicated.
(in millions)
September 30,
2011
December 31,
2010
Derivative receivables balance (net of derivatives CVA)
$
108,853

$
80,481

Derivatives CVA(a)
(7,345
)
(4,362
)
Derivative payables balance (net of derivatives DVA)
79,249

69,219

Derivatives DVA
(1,820
)
(882
)
Structured notes balance (net of structured notes DVA)(b)(c)
50,062

53,139

Structured notes DVA
(2,219
)
(1,153
)
(a)
Derivatives credit valuation adjustments (“CVA”), gross of hedges, includes results managed by the Credit Portfolio and other lines of business within the Investment Bank (“IB”).
(b)
Structured notes are recorded within long-term debt, other borrowed funds or deposits on the Consolidated Balance Sheets, based on the tenor and legal form of the note.
(c)
Structured notes are measured at fair value based on the Firm’s election under the fair value option. For further information on these elections, see Note 4 on pages 116–118 of this Form 10-Q.
The following table provides the impact of credit adjustments on earnings in the respective periods, excluding the effect of any hedging activity.
 
Three months ended September 30,
 
Nine months ended September 30,
(in millions)
2011
 
2010
 
2011
 
2010
Credit adjustments:
 
 
 
 
 
 
 
Derivative CVA(a) 
$
(3,270
)
 
$
(527
)
 
$
(2,983
)
 
$
(1,441
)
Derivative DVA
984

 
(247
)
 
938

 
44

Structured note DVA(b) 
901

 
(246
)
 
1,066

 
450

(a)
Derivatives CVA, gross of hedges, includes results managed by the Credit Portfolio and other lines of business within IB.
(b)
Structured notes are measured at fair value based on the Firm’s election under the fair value option. For further information on these elections, see Note 4 on pages 116–118 of this Form 10-Q.
Additional disclosures about the fair value of financial instruments (including financial instruments not carried at fair value)
The following table presents the carrying values and estimated fair values of financial assets and liabilities. For additional information regarding the financial instruments within the scope of this disclosure, and the methods and significant assumptions used to estimate their fair value, see Note 3 on pages 170–187 of JPMorgan Chase’s 2010 Annual Report.
The following table presents the carrying values and estimated fair values of financial assets and liabilities.
 
September 30, 2011
 
December 31, 2010
(in billions)
Carrying
value
Estimated
fair value
Appreciation/
(depreciation)
 
Carrying
value
Estimated
fair value
Appreciation/
(depreciation)
Financial assets
 
 
 
 
 
 
 
Assets for which fair value approximates carrying value
$
185.6

$
185.6

$

 
$
49.2

$
49.2

$

Accrued interest and accounts receivable
72.1

72.1


 
70.1

70.1


Federal funds sold and securities purchased under resale agreements (included $22.2 and $20.3 at fair value)
248.0

248.0


 
222.6

222.6


Securities borrowed (included $14.6 and $14.0 at fair value)
131.6

131.6


 
123.6

123.6


Trading assets
461.5

461.5


 
489.9

489.9


Securities (included $339.3 and $316.3 at fair value)
339.3

339.3


 
316.3

316.3


Loans (included $2.0 and $2.0 at fair value)(a)
668.5

669.3

0.8

 
660.7

663.5

2.8

Mortgage servicing rights at fair value
7.8

7.8


 
13.6

13.6


Other (included $16.1 and $18.2 at fair value)
68.1

68.6

0.5

 
64.9

65.0

0.1

Total financial assets
$
2,182.5

$
2,183.8

$
1.3

 
$
2,010.9

$
2,013.8

$
2.9

Financial liabilities
 
 
 
 
 
 
 
Deposits (included $4.8 and $4.4 at fair value)
$
1,092.7

$
1,093.4

$
(0.7
)
 
$
930.4

$
931.5

$
(1.1
)
Federal funds purchased and securities loaned or sold under repurchase agreements (included $7.0 and $4.1 at fair value)
238.6

238.6


 
276.6

276.6


Commercial paper
51.1

51.1


 
35.4

35.4


Other borrowed funds (included $9.4 and $9.9 at fair value)(b)
29.3

29.3


 
34.3

34.3


Trading liabilities
155.8

155.8


 
146.2

146.2


Accounts payable and other liabilities (included $0.1 and $0.2 at fair value)
164.9

164.8

0.1

 
138.2

138.2


Beneficial interests issued by consolidated VIEs (included $0.9 and $1.5 at fair value)
66.0

66.3

(0.3
)
 
77.6

77.9

(0.3
)
Long-term debt and junior subordinated deferrable interest debentures (included $35.9 and $38.8 at fair value)(b)
273.7

271.1

2.6

 
270.7

271.9

(1.2
)
Total financial liabilities
$
2,072.1

$
2,070.4

$
1.7

 
$
1,909.4

$
1,912.0

$
(2.6
)
Net appreciation
 
 
$
3.0

 
 
 
$
0.3

(a)
Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. The difference between the estimated fair value and carrying value of a financial asset or liability is the result of the different methodologies used to determine fair value as compared with carrying value. For example, credit losses are estimated for a financial asset’s remaining life in a fair value calculation but are estimated for a loss emergence period in a loan loss reserve calculation; future loan income (interest and fees) is incorporated in a fair value calculation but is generally not considered in a loan loss reserve calculation. For a further discussion of the Firm’s methodologies for estimating the fair value of loans and lending-related commitments, see Note 3 pages 171–173 of JPMorgan Chase’s 2010 Annual Report.
(b)
Effective January 1, 2011, $23.0 billion of long-term advances from Federal Home Loan Banks (“FHLBs”) were reclassified from other borrowed funds to long-term debt. The prior-year period has been revised to conform with the current presentation.
The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated Balance Sheets, nor are they actively traded. The carrying value and estimated fair value of the Firm’s wholesale lending-related commitments were as follows for the periods indicated.
 
September 30, 2011
 
December 31, 2010
(in billions)
Carrying
value(a)
Estimated
fair value
 
Carrying
value(a)
Estimated
fair value
Wholesale lending-related commitments
$0.7
$3.3
 
$0.7
$0.9
(a)
Represents the allowance for wholesale lending-related commitments. Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which are recognized at fair value at the inception of guarantees.
The Firm does not estimate the fair value of consumer lending-related commitments. In many cases, the Firm can reduce or cancel these commitments by providing the borrower notice or, in some cases, without notice as permitted by law. For a further discussion of the valuation of lending-related commitments, see Note 3 on pages 171–173 of JPMorgan Chase’s 2010 Annual Report.
Trading assets and liabilities - average balances
Average trading assets and liabilities were as follows for the periods indicated.
 
Three months ended September 30,
 
Nine months ended September 30,
(in millions)
2011
 
2010
 
2011
 
2010
Trading assets – debt and equity instruments(a)
$
377,840

 
$
347,990

 
$
405,861

 
$
340,181

Trading assets – derivative receivables
96,612

 
92,857

 
88,344

 
83,702

Trading liabilities – debt and equity instruments(a)(b)
85,541

 
79,838

 
84,246

 
76,104

Trading liabilities – derivative payables
75,828

 
69,350

 
71,058

 
63,688

(a)
Balances reflect the reduction of securities owned (long positions) by the amount of securities sold, but not yet purchased (short positions) when the long and short positions have identical CUSIP numbers.
(b)
Primarily represent securities sold, not yet purchased.